NEUMOLOGÍA PEDIÁTRICA

46 / 64

90 Contenido disponible en
penicillin susceptibility breakpoints versus Streptococcus pneumoniae:
coping with antimicrobial susceptibility in an era of resistance. Clin
Infect Dis 2009; 48: 1596-600.
14. Song JH, Jung SI, Ko KS, et al. High prevalence of antimicrobial
resistance among clinical Streptococcus pneumoniae isolates in Asia
(an ANSORP study). Antimicrob Agents Chemother 2004; 48:
2101-7.
15. Centers for Diseases Control. Effect of new susceptibility
breakpoints on reporting of resistance in Streptococcus pneumoniae-
United States, 2003. Morb Mortal Wekly Rep 2004; 53: 152-4.
16. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic
response to oral cephalosporins in acute otitis media caused by
pneumococci with intermediate resistence to penicillin. Pediatr
Infect Dis J 1996; 15: 980-5.
17. Catalan MJ, Fernández JM, Vázquez A, Varela de Seijas E, Suárez A,
de Quiros JCL. Failure of cefotaxime in the treatment of meningitis
due to relatively resistant Streptococcus pneumoniae. Clin Infect Dis
1994; 18: 766-9.
18. Sloas MM, Barrett FF, Chesney PJ, et al. Cephalosporin treatment
failure in penicillin and cephalosporin-resistant Streptococcus
pneumoniae meningitis. Pediatr Infect Dis J 1992; 11: 662-6.
19. Grant GB, Campbell H, Dowell SF, Graham SM, Klugman
KP, Mulholland EK, Steinhoff M, Weber MW, Qazi S.
Recommendations for treatment of childhood non-severe
pneumonia. Lancet Infect Dis 2009; 9: 185-96.
20. Fraimow HS, Tsigrelis C. Antimicrobial Resistance in the Intensive
Care Unit: Mechanisms, Epidemiology, and Management of Specific
Resistant Pathogens. Crit Care Clin 211; 27: 163-205.
21. Agudelo CI, Sanabria O, Ovalle MV, et al. Vigilancia por el
laboratorio de Streptococcus pneumoniae, aislado de procesos
invasores en niños menores de 5 años: actualización de los datos
1994-2000. IQUEN 2001; 6: 45-54.
22. Instituto nacional de salud Colombia. Grupo de Microbiología
23. Reichler MR, Allphin AA, Breiman RF, et al. Spread of multiply
resistant Streptococcus pneumoniae at a day-care center in Ohio. J
Infect Dis 1992; 166: 1346-53.
24. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistance
Streptococcus pneumoniae in acute otitis media: risk factors,
susceptibility patterns and antimicrobial management. Pediatr Infect
Dis J 1995; 14: 751-9.
25. Mularczyk MA, Leophonte P, Rouquet RM, and the French Study
Group for Pneumonia. A prospective hospital study of 363
pneumococcal pneumonia cases in adults. In: Program and abstract
of the 31st Interscience Conference on Antimicrobial Agents
and Chemotherapy; September 28-October 1, 1997; Toronto,
Ontario, Canada. Abstract K-94.
26. Deeks SL, Palacio R, Ruvinsky R, et al. Risk factors and course of
illness among children with invasive penicillin-resistant Streptococcus
pneumoniae. The Streptococcus pneumoniae Working Group.
Pediatrics 1999; 103: 409-13.
27. Clifford V, Tebruegge M, Vandeleur M, Curtis N. Can pneumonia
caused by penicillinresistant Streptococcus pneumoniae be treated
with Penicillin? Arch Dis Child 2010; 95: 73-7.
28. Cardoso MR, Nascimento-Carvalho CM, Ferrero F, Berezin ER,
Ruvinsky R, Camargos PA, Sant’Anna CC, et al. Penicillin-resistant
pneumococcus and risk of treatment failure in pneumonia. Arch Dis
Child 2008; 93: 221-5.
29. Pirez MC, Martínez O, Ferrari AM, et al. Standard case
management of pneumonia in hospitalized children in Uruguay,
1997 to 1998. Pediatr Infect Dis J 2001; 20: 283-9.
30. Heffelfinger J, Dowwell S, Jorgensen J. Management of
Community-Acquiered Pneumonia in the era of Pneumococcal
Resistance. A report from Drug-Resistant Streptococcus pneumoniae
Therapeutic Working Group. Arch Intern Med. 2000; 160: 1399-
408.
31. Choi E-H, Leetl J. Clinical outcome of invasive infectous by
penicillin-resistant Streptococcus pneumoniae in Korean children.
Clinic Infect Dis 1998; 26: 1346-54.
32. Buckingham S, Brown S, San Joaquin V. Breakthrough bacteremia
and meningitis during treatment with cefalosporins parenterally for
pneumococcal pneumonia. J Pediatr 1998; 132: 17-6.
33. Agudelo BI, Arango M, Cala LL, Manotas M, Vásquez C. Guía de
práctica clínica en el tratamiento del niño con neumonía adquirida
en la comunidad. Asociación Colombiana de Neumología
Pediátrica Guías de práctica clínica 2010 Guía No. 5 http://issuu.
com/acnp/docs/neumonia1?e=3790791/2606451
34. Bradley JS, Byington CL, Shah SS, et al. The Management of
Community-Acquired Pneumonia in Infants and Children Older
Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric
Infectious Diseases Society and the Infectious Diseases Society of
America. Clin Infect Dis 2011; 53: e25-76.
Neumol Pediatr 2013; 8 (2): 86-90. Tratamiento de la neumonía por Streptococcus pneumoniae y consideraciones de resistencia - Agudelo B.